Invention Grant
- Patent Title: Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
-
Application No.: US15040375Application Date: 2016-02-10
-
Publication No.: US10017576B2Publication Date: 2018-07-10
- Inventor: Henrik Clausen , Joy Burchell , Ulla Mandel , Anne Louise Sørensen , Mads Agervig Tarp , Joyce Taylor-Papadimitriou
- Applicant: Københavns Universitet , Cancer Research Technology Limited
- Applicant Address: DK Copenhagen GB London
- Assignee: Københavns Universitet,Cancer Research Technology Limited
- Current Assignee: Københavns Universitet,Cancer Research Technology Limited
- Current Assignee Address: DK Copenhagen GB London
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: C40B50/06
- IPC: C40B50/06 ; C07K16/28 ; A61K39/00 ; C07K14/47 ; C07K16/30 ; G01N33/574 ; G01N33/68 ; A61K47/64 ; C40B30/04
Abstract:
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine comprising the immunogenic glycopeptide. Another aspect is an antibody generated using the immunogenic glycopeptide and the use of said antibody in therapy and diagnosis.
Public/Granted literature
- US20160176975A1 GENERATION OF A CANCER-SPECIFIC IMMUNE RESPONSE TOWARD MUC1 AND CANCER SPECIFIC MUC1 ANTIBODIES Public/Granted day:2016-06-23
Information query
